Predictions
Bausch Health Companies Inc.
Start price
Target price
Perf. (%)
€4.11
28.07.22
28.07.22
-
28.07.23
28.07.23
35.16%
14.05.23
14.05.23
Helius Medical Technologies Inc
Start price
Target price
Perf. (%)
€1.85
03.08.22
03.08.22
-
03.08.23
03.08.23
-92.76%
14.05.23
14.05.23
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€5.55
03.01.23
03.01.23
-
03.01.24
03.01.24
78.44%
14.05.23
14.05.23
Could be worthwhile Investment >10% per year
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€25.86
27.10.21
27.10.21
€40.00
31.12.23
31.12.23
-59.32%
08.05.23
08.05.23
Could be very worthwhile Investment >20% year
Fennec Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€7.45
18.10.21
18.10.21
€12.00
31.12.23
31.12.23
-2.68%
08.05.23
08.05.23
Could be very worthwhile Investment >20% year
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€3.49
10.10.21
10.10.21
€5.00
31.12.23
31.12.23
-32.83%
08.05.23
08.05.23
Could be very worthwhile Investment >20% year
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€6.46
04.01.23
04.01.23
€12.00
31.12.25
31.12.25
63.49%
05.05.23
05.05.23
Could be very worthwhile Investment >20% year
BELLUS Health Inc.
Start price
Target price
Perf. (%)
€13.20
18.04.23
18.04.23
-
18.04.24
18.04.24
-1.52%
27.04.23
27.04.23
Growths slower than the competition
Higher risks for its business
Organigram Holdings Inc.
Start price
Target price
Perf. (%)
€4.23
28.05.22
28.05.22
-
28.05.23
28.05.23
-56.27%
24.04.23
24.04.23
Probably not worthwhile Investment
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€9.78
03.04.23
03.04.23
-
03.04.24
03.04.24
0.20%
15.04.23
15.04.23
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€3.79
20.09.21
20.09.21
-
20.09.25
20.09.25
-26.16%
03.04.23
03.04.23
Could be worthwhile Investment >10% per year
Canopy Growth Corp
Start price
Target price
Perf. (%)
€1.77
21.03.23
21.03.23
-
21.03.24
21.03.24
-7.32%
02.04.23
02.04.23
Could be very worthwhile Investment >20% year
InMed Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€16.34
12.09.22
12.09.22
-
12.09.23
12.09.23
-93.70%
02.04.23
02.04.23
Could be very worthwhile Investment >20% year
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€10.25
31.03.23
31.03.23
-
31.03.24
31.03.24
-4.55%
01.04.23
01.04.23
InMed Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€1.30
20.03.23
20.03.23
-
20.03.24
20.03.24
6.18%
23.03.23
23.03.23
Could be worthwhile Investment >10% per year
Capable Management
Good culture
Little innovation
Promis Neurosciences Inc.
Start price
Target price
Perf. (%)
€5.37
21.07.22
21.07.22
€5.30
21.07.23
21.07.23
-21.42%
11.03.23
11.03.23
ROE lower than 10% per year
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Canopy Growth Corp
Start price
Target price
Perf. (%)
€3.63
19.11.22
19.11.22
€2.50
19.11.23
19.11.23
-46.91%
11.03.23
11.03.23
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
Risky balance sheet
Aphria Inc.
Start price
Target price
Perf. (%)
€12.71
01.03.23
01.03.23
€14.00
-
02.03.23
02.03.23
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
